You searched for: prolongation (Italienska - Spanska)

titolo : prolongation du programme eureka itea — aide d'État n 73/2000
denominación : prolongation du programme eureka itea — aide d'etat n 73/2000

the ticket should allow for changes ( in case of a prolongation of your contract , for instance ) .
the ticket should allow for changes ( in case of a prolongation of your contract , for instance ) .

titolo : prolongation du régime d'aides de l'ademe à la recherche et au développement n 84/2003
denominación : prolongation du régime d'aides de l'ademe à la recherche et au développement n 84/2003

les autorités françaises ont soumis des informations par lettre du 7 novembre 2003 après avoir demandé la prolongation du délai de réponse (par lettre du 30 septembre 2003) que les services de la commission leur avaient accordée par courrier du 7 octobre 2003.
les autorités françaises ont soumis des informations par lettre du 7 novembre 2003 après avoir demandé la prolongation du délai de réponse (par lettre du 30 septembre 2003) que les services de la commission leur avaient accordée par courrier du 7 octobre 2003.

63) note for guidance on photosafety testing points to consider document on the need for assessment of reproductive toxicity of human insulin analogues discussion paper on environmental risk assessments of non-gmo containing medicinal products for human use non-clinical documentation of medicinal products with ‘ well-established use’ note for guidance on the need for non-clinical testing of pharmaceuticals in juvenile animals discussion paper on the non-clinical safety studies to support single low dose clinical screening studies in man note for guidance on specification limits for residues for heavy metal catalysts in medicinal products points to consider on xenogeneic cell therapy note for guidance on comparability of biotechnology products pre-clinical and clinical issues points to consider on the assessment of the potential for qt interval prolongation by non-cardiovascular medicinal products note for guidance on risk assessment of medicinal products on human reproductive and development toxicities: from data to labelling
63) note for guidance on photosafety testing points to consider document on the need for assessment of reproductive toxicity of human insulin analogues discussion paper on environmental risk assessments of non-gmo containing medicinal products for human use non-clinical documentation of medicinal products with ‘ well-established use’ note for guidance on the need for non-clinical testing of pharmaceuticals in juvenile animals discussion paper on the non-clinical safety studies to support single low dose clinical screening studies in man note for guidance on specification limits for residues for heavy metal catalysts in medicinal products points to consider on xenogeneic cell therapy note for guidance on comparability of biotechnology products pre-clinical and clinical issues points to consider on the assessment of the potential for qt interval prolongation by non-cardiovascular medicinal products note for guidance on risk assessment of medicinal products on human reproductive and development toxicities: from data to labelling